Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Ardent To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Ardent between July 18, 2024 and November 12, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information]New York, New York--(Newsfile Corp. - January 21, 2026) ...

Core Viewpoint - A class action lawsuit has been filed against Ardent Health, Inc. for allegedly misleading investors regarding its accounts receivable practices during the Class Period from July 18, 2024, to November 12, 2025 [4]. Group 1: Lawsuit Details - The lawsuit claims that Ardent misrepresented its method of determining the collectability of accounts receivable, stating it used detailed historical reviews, while in reality, it relied on a 180-day cliff for reserving accounts [4]. - On November 12, 2025, Ardent disclosed a $43 million reduction in revenue and a $54 million increase in professional liability reserves, leading to a significant drop in share price by approximately 33.8% [5]. Group 2: Investor Actions - Investors have until March 9, 2026, to apply to be appointed as lead plaintiff in the class action, which allows them to oversee litigation and influence key decisions [2]. - The law firm Kirby McInerney LLP is handling the case and encourages affected investors to contact them for more information [7].

Core Viewpoint - The Ardent Health class action lawsuit alleges that the company and its executives made misleading statements regarding financial practices and failed to disclose critical information about accounts receivable and liability reserves, leading to significant financial losses for investors during the specified class period [1][3][4]. Company Overview - Ardent Health, Inc. operates a network of hospitals and clinics providing various healthcare services [2]. Allegations of the Lawsuit - The lawsuit claims that Ardent Health did not rely on accurate methods for determining the collectability of accounts receivable, which allowed the company to report inflated figures [3]. - It is alleged that Ardent Health's accounts receivable framework utilized a 180-day cliff for reserving accounts, delaying the recognition of losses on uncollectible accounts [3]. - The lawsuit states that Ardent Health did not maintain sufficient professional malpractice liability insurance and that its reserves were inadequate to cover increasing social inflationary pressures in medical malpractice cases [3]. Financial Impact - On November 12, 2025, Ardent Health reported a $43 million decrease in third-quarter 2025 revenue due to revised accounts receivable collectability assessments after transitioning to a new revenue accounting system [4]. - The company also cut its 2025 EBITDA guidance by approximately 9.6%, from a range of $575 million - $615 million to $530 million - $555 million, citing persistent industry-wide cost pressures [4]. - Following these announcements, Ardent Health's stock price fell nearly 34% [4]. Lead Plaintiff Process - The Private Securities Litigation Reform Act of 1995 allows investors who purchased Ardent Health securities during the class period to seek appointment as lead plaintiff in the lawsuit, representing the interests of all class members [5].

Core Viewpoint - The Gross Law Firm is notifying shareholders of Ardent Health, Inc. regarding a class action lawsuit due to alleged false statements and misleading financial practices related to accounts receivable and professional liability reserves [1][3]. Group 1: Allegations - The complaint alleges that Ardent Health did not rely on "detailed reviews of historical collections" for determining the collectability of accounts receivable, instead using a 180-day cliff for reserving accounts, which inflated reported receivables [3]. - It is claimed that Ardent Health's professional liability reserves were insufficient to cover claims due to "significant social inflationary pressure" in medical malpractice cases, particularly in the New Mexico market [3]. Group 2: Class Action Details - The class period for the lawsuit is from July 18, 2024, to November 12, 2025, and shareholders are encouraged to register for participation by March 9, 2026 [4]. - Shareholders who register will receive updates through a portfolio monitoring software regarding the case's progress [4]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit and fraud, aiming to ensure responsible business practices [5].

SAN FRANCISCO, Jan. 21, 2026 /PRNewswire/ -- National shareholder rights firm Hagens Berman is notifying Ardent Health, Inc. (NYSE: ARDT) investors that a securities class action lawsuit has been filed against the company and certain of its executives following the company's disastrous Q3 2025 financial results. Hagens Berman is investigating the alleged claims that Ardent misled investors about its revenue recognition systems and the adequacy of its professional liability reserves. The firm urges investors ...

New York, New York--(Newsfile Corp. - January 21, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Ardent Health, Inc. (NYSE: ARDT) between July 18, 2024 and November 12, 2025, both dates inclusive (the "Class Period"), of the important March 9, 2026 lead plaintiff deadline.SO WHAT: If you purchased Ardent Health securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency f ...

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Ardent Health (ARDT) To Contact Him Directly To Discuss Their Options If you purchased or acquired Ardent Health securities between July 18, 2024 and November 12, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Melissa Forunato directly at (212) 355-4648. Click here to participate in the action. NEW YORK, Jan. 21, 2026 (GLOBE NEWSWIRE) -- What’s Ha ...

NEW YORK, Jan. 21, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Ardent Health, Inc. ("Ardent Health, Inc." or the "Company") (NYSE: ARDT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Ardent Health, Inc. investors who were adversely affected by alleged securities fraud between July 18, 2024 and November 12, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/arden ...

New York, New York--(Newsfile Corp. - January 21, 2026) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that it has filed a class action lawsuit against Ardent Health, Inc. (NYSE: ARDT) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from potential violations of the federal securities laws. If you invested in Ardent Health, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/ardent-heal ...

LOS ANGELES, Jan. 20, 2026 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Ardent Health, Inc. ("Ardent" or the "Company") (NYSE: ARDT) have opportunity to lead the securities fraud class action lawsuit. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ARDENT HEALTH, INC. (ARDT), CLICK HERE BEFORE MARCH 9, 2026 (THE LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT. What Is The Lawsuit About? The complaint filed alleges that, betwe ...